Berkshire, United Kingdom

Praful Chovatia

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Praful Chovatia. Retrieved from https://idiyas.com/inventor/praful-chovatia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Praful Chovatia: Innovator in Pharmaceutical Chemistry

Introduction

Praful Chovatia is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new medicinal compounds. His work focuses on innovative solutions for chronic pain management.

Latest Patents

Praful Chovatia holds a patent for Triazine-oxadiazoles. This invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification. The patent also covers processes for the preparation of such derivatives, pharmaceutical compositions comprising these derivatives, and their application as a medicament for the treatment of chronic pain. He has 1 patent to his name.

Career Highlights

Chovatia is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development of innovative pharmaceutical products aimed at improving patient outcomes. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Praful has collaborated with esteemed colleagues, including Oliver Barker and Jonathan Mark Bentley. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Praful Chovatia's contributions to pharmaceutical chemistry and his innovative patent for Triazine-oxadiazoles highlight his commitment to improving healthcare solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…